567 related articles for article (PubMed ID: 34796710)
1. Natural immune response and protection from SARS-CoV-2 reinfection.
Margiotti K; Fabiani M; Mesoraca A; Giorlandino C
Acta Virol; 2021; 65(4):333-338. PubMed ID: 34796710
[TBL] [Abstract][Full Text] [Related]
2. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract.
Hansen F; Meade-White K; Clancy C; Rosenke R; Okumura A; Hawman DW; Feldmann F; Kaza B; Jarvis MA; Rosenke K; Feldmann H
Cell Rep; 2022 Mar; 38(11):110515. PubMed ID: 35263638
[TBL] [Abstract][Full Text] [Related]
4. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
5. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2.
Sharma R; Sardar S; Mohammad Arshad A; Ata F; Zara S; Munir W
Am J Case Rep; 2020 Dec; 21():e927154. PubMed ID: 33257644
[TBL] [Abstract][Full Text] [Related]
6. Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.
Fintelman-Rodrigues N; da Silva APD; Dos Santos MC; Saraiva FB; Ferreira MA; Gesto J; Rodrigues DAS; Vale AM; de Azevedo IG; Soares VC; Jiang H; Tan H; Tschoeke DA; Sacramento CQ; Bozza FA; Morel CM; Bozza PT; Souza TML
Emerg Infect Dis; 2021 May; 27(5):1446-1453. PubMed ID: 33797393
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of SARS-CoV-2-Specific B Cell Memory Responses in Infected and Vaccinated Individuals.
Fabiani M; Margiotti K; Monaco F; Viola A; Cima A; Mesoraca A; Giorlandino C
Viral Immunol; 2023 Jun; 36(5):343-350. PubMed ID: 37140898
[TBL] [Abstract][Full Text] [Related]
8. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
[TBL] [Abstract][Full Text] [Related]
9. An update on host immunity correlates and prospects of re-infection in COVID-19.
Negi N; Maurya SP; Singh R; Das BK
Int Rev Immunol; 2022; 41(4):367-392. PubMed ID: 34961403
[TBL] [Abstract][Full Text] [Related]
10. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
[TBL] [Abstract][Full Text] [Related]
11. An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19.
Soleimanian S; Alyasin S; Sepahi N; Ghahramani Z; Kanannejad Z; Yaghobi R; Karimi MH
Front Immunol; 2022; 13():884879. PubMed ID: 35669767
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
13. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
Loos C; Atyeo C; Fischinger S; Burke J; Slein MD; Streeck H; Lauffenburger D; Ryan ET; Charles RC; Alter G
mSphere; 2020 Sep; 5(5):. PubMed ID: 32878931
[TBL] [Abstract][Full Text] [Related]
14. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
Deng W; Bao L; Liu J; Xiao C; Liu J; Xue J; Lv Q; Qi F; Gao H; Yu P; Xu Y; Qu Y; Li F; Xiang Z; Yu H; Gong S; Liu M; Wang G; Wang S; Song Z; Liu Y; Zhao W; Han Y; Zhao L; Liu X; Wei Q; Qin C
Science; 2020 Aug; 369(6505):818-823. PubMed ID: 32616673
[TBL] [Abstract][Full Text] [Related]
15. Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model.
Pulit-Penaloza JA; Belser JA; Sun X; Pappas C; Brock N; Kieran TJ; Ritter JM; Seixas JN; Jones J; Basu Thakur P; Pusch E; Wang L; Tumpey TM; Wentworth DE; Zhou B; Maines TR
mBio; 2022 Oct; 13(5):e0242122. PubMed ID: 36135377
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of natural immune protection against COVID-19 reinfection: systematic review with meta-analysis.
Moundir A; Errami A; El Bakkouri J; Ben Abdelaziz A; Bousfiha AA
Tunis Med; 2023 Feb; 101(2):245-252. PubMed ID: 37682268
[TBL] [Abstract][Full Text] [Related]
17. Germinal Center-Induced Immunity Is Correlated With Protection Against SARS-CoV-2 Reinfection But Not Lung Damage.
Kim G; Kim DH; Oh H; Bae S; Kwon J; Kim MJ; Lee E; Hwang EH; Jung H; Koo BS; Baek SH; Kang P; An YJ; Park JH; Park JH; Lyoo KS; Ryu CM; Kim SH; Hong JJ
J Infect Dis; 2021 Dec; 224(11):1861-1872. PubMed ID: 34718664
[TBL] [Abstract][Full Text] [Related]
18. Reinfection With SARS-CoV-2: Implications for Vaccines.
Cohen JI; Burbelo PD
Clin Infect Dis; 2021 Dec; 73(11):e4223-e4228. PubMed ID: 33338197
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.
Guthmiller JJ; Stovicek O; Wang J; Changrob S; Li L; Halfmann P; Zheng NY; Utset H; Stamper CT; Dugan HL; Miller WD; Huang M; Dai YN; Nelson CA; Hall PD; Jansen M; Shanmugarajah K; Donington JS; Krammer F; Fremont DH; Joachimiak A; Kawaoka Y; Tesic V; Madariaga ML; Wilson PC
mBio; 2021 Jan; 12(1):. PubMed ID: 33468695
[TBL] [Abstract][Full Text] [Related]
20. Duration of immune protection of SARS-CoV-2 natural infection against reinfection.
Chemaitelly H; Nagelkerke N; Ayoub HH; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
J Travel Med; 2022 Dec; 29(8):. PubMed ID: 36179099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
